Dr. Jacalyn Howze Reese, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Psc 810 Box 35, Fpo, AE 09589 Phone: 251-648-7507 |
Dr. Allison Angeline Coates Eubanks, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: Psc 819 Box 4581, Fpo, AE 09645 Phone: 314-727-3511 |
Michael Thomas Acromite, M.D., MSPH Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: Uss Dwight D Eisenhower, Medical Department, Fpo, AE 09532 Phone: 757-323-1200 |
Dr. Tracie Christine Snider, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Psc 819, Box 4642, Fpo, AE 09645 Phone: 602-774-4510 |
News Archive
Symphogen A/S today announced that it has initiated a Phase 1/2 human clinical trial in the US to evaluate the safety, tolerability and efficacy of its drug candidate Sym004 for the treatment of advanced solid tumors. Sym004 is composed of two anti-epidermal growth factor receptor monoclonal antibodies targeting different nonoverlapping EGFR epitopes.
Computer simulations of the faces behind the voices heard by sufferers of schizophrenia may give patients the power to cope better with these distressing hallucinations.
Repros Therapeutics Inc. today announced it has completed two animal model studies of the use of Proellex® in a vaginally administered formulation that demonstrated effects on progesterone sensitive tissues equivalent to the highest oral dose formerly in development by the Company.
MedImmune continues to advance its commitment to pediatric research with today's announcement of the first observational prospective study designed to assess the burden of respiratory syncytial virus (RSV) among preterm infants 32-to-35 weeks gestational age (GA) in outpatient settings during their first year of life.
› Verified 8 days ago